Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A diffuse subtype of classical Hodgkin lymphoma which is rich in Hodgkin and Reed-Sternberg cells and/or depleted in non-neoplastic lymphocytes. (WHO, 2008)
Biomarker and diagnostic research for Hodgkin's lymphoma, lymphocytic depletion has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
186 publications have been identified in PubMed for Hodgkin's lymphoma, lymphocytic depletion. Kisho has analyzed 144 by research type. Research spans Clinical Trial Publication (26%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
26% |
Research summaries | 33 | 23% |
Disease patterns and progression | 30 | 21% |
Laboratory research | 21 | 15% |
Testing and diagnosis research | 13 | 9% |
Patient case studies | 6 | 4% |
New treatment approaches | 3 | 2% |
Liu J (2026). [PMID: 42160424](https://pubmed.ncbi.nlm.nih.gov/42160424/). *Sci Adv*. [Gene Therapy / Novel Therapeutics]
Toner K (2026). [PMID: 40990939](https://pubmed.ncbi.nlm.nih.gov/40990939/). *Blood Adv*. [Clinical Trial Publication]
Kristo F (2026). [PMID: 41524385](https://pubmed.ncbi.nlm.nih.gov/41524385/). *Future Oncol*. [Review / Meta-Analysis]
Abramson JS (2026). [PMID: 41460964](https://pubmed.ncbi.nlm.nih.gov/41460964/). *Blood*. [Clinical Trial Publication]
Asees M (2026). [PMID: 42065778](https://pubmed.ncbi.nlm.nih.gov/42065778/). *Ann Hematol*. [Basic Science / Preclinical]
Gloghini A (2026). [PMID: 42122242](https://pubmed.ncbi.nlm.nih.gov/42122242/). *Cancers (Basel)*. [Review / Meta-Analysis]
D'Angelo CR (2026). [PMID: 42166518](https://pubmed.ncbi.nlm.nih.gov/42166518/). *Cancer J*. [Review / Meta-Analysis]
Sha C (2026). [PMID: 41708412](https://pubmed.ncbi.nlm.nih.gov/41708412/). *Hematology/oncology clinics of North America*. [Review / Meta-Analysis]
Desai SH (2026). [PMID: 41405496](https://pubmed.ncbi.nlm.nih.gov/41405496/). *Blood*. [Clinical Trial Publication]
Gowdy SC (2026). [PMID: 41535222](https://pubmed.ncbi.nlm.nih.gov/41535222/). *Br J Haematol*. [Review / Meta-Analysis]
AI-curated news mentioning Hodgkin's lymphoma, lymphocytic depletion
Updated Apr 1, 2026
Recent research highlights a significant breakthrough in understanding the intersection of cardio-obstetric care and Hodgkin's lymphoma. This study may pave the way for improved management strategies in pregnant patients diagnosed with this rare cancer.
A recent study highlights vanishing bile duct syndrome as a rare hepatic paraneoplastic syndrome associated with Hodgkin's lymphoma. This discovery may enhance understanding of the disease's complications and guide future research.